{"disease":{"id":"chronic-hand-dermatitis","name":"chronic hand dermatitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05026554","title":"Characterization of Chronic Hand Eczema","phase":"","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Dr. Robert Bissonnette","has_results":false},{"nct_id":"NCT03728504","title":"Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Asana BioSciences","has_results":true},{"nct_id":"NCT05293717","title":"Topical Ruxolitinib in Chronic Hand Dermatitis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"University of Rochester","has_results":true},{"nct_id":"NCT03741933","title":"Apremilast and Moderate to Severe Chronic Hand Dermatitis","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"George Washington University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}